Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
46°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(NY:
KVUE
)
22.73
-0.20 (-0.87%)
Official Closing Price
Updated: 7:00 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about KVUE
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
This Big New Development Could Be Bullish for Kenvue Stock
October 30, 2024
Can tinkering around the edges actually make this stock more attractive?
Via
The Motley Fool
3 Dividend Stocks to Double Up on Right Now
October 27, 2024
While tech-based growth stocks might seem like the right play, you can't ignore dividends if you want to have a strong portfolio.
Via
The Motley Fool
Billionaire Ken Griffin Just Increased His Position in This Dividend Stock by 5,848%. Here's Why Now May Be a Great Time to Buy.
October 26, 2024
Ken Griffin's Citadel just added 18 million shares of an under-the-radar consumer health stock.
Via
The Motley Fool
Meet the 3.6%-Yielding Dividend King Stock That's Up 25% in 3 Months
October 26, 2024
An activist investor is taking a stake in Kenvue stock.
Via
The Motley Fool
Is Kenvue Stock a Buy Now?
October 25, 2024
The growth rate of the consumer healthcare business could accelerate now that an activist investor is involved.
Via
The Motley Fool
10 Analysts Have This To Say About Kenvue
October 22, 2024
Via
Benzinga
Navigating 10 Analyst Ratings For Kenvue
October 11, 2024
Via
Benzinga
P/E Ratio Insights for Kenvue
September 27, 2024
Via
Benzinga
There are signs that NYSE:KVUE may be ready to breakout.
September 26, 2024
KENVUE INC is setting up nicely for a breakout.
Via
Chartmill
Analyst Ratings For Kenvue
September 23, 2024
Via
Benzinga
Starboard Hammers Pfizer Execs For Failing To Deliver On 'Best Pipeline' Promises
October 22, 2024
The activist investor says Pfizer has underperformed its peers and the broader market since 2019.
Via
Investor's Business Daily
Nvidia Among Five Best S&P 500 Stocks Today
October 21, 2024
Pfizer spinoff Kenvue led the S&P 500 on Monday. Nvidia was close behind.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Dow Drops 320 Points as Stocks Cool Off
October 21, 2024
Stocks are stumbling out of the gate this week.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
What's Going On With Kenvue Stock Monday?
October 21, 2024
Kenvue Inc. (NYSE:KVUE) shares are moving higher Monday following a report suggesting activist investor Starboard Value has acquired a stake in the company.
Via
Benzinga
Stocks Fall As Treasury Yields, Dollar Rise; Nvidia Hits Record Highs: What's Driving Markets Monday?
October 21, 2024
U.S. major indices fell on Monday as rising Treasury yields and a strengthening dollar dampened risk sentiment. Investors are reassessing the economic outlook and weighing potential risks tied to the...
Via
Benzinga
Starboard Value Buys Into Dow Jones Spinoff; Elf Beauty Rallies
October 21, 2024
Elf Beauty appeared to rally along with KVUE on Monday.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Activist Investor Starboard Acquires Stake In Band-Aid Maker Kenvue, Shares Jump
October 21, 2024
Activist hedge fund Starboard Value has reportedly taken a stake in Kenvue, sparking a pre-market stock surge.
Via
Talk Markets
Tylenol, Listerine Maker Kenvue Under Activist Spotlight With Starboard Value Stake — Overhaul Ahead For The Johnson & Johnson Spinoff?
October 20, 2024
Starboard Value, an activist investor, has reportedly acquired a substantial stake in Kenvue Inc, the company behind popular consumer products like Tylenol and Listerine.
Via
Benzinga
All It Takes Is $1,000 Invested in Each of These 3 Dividend Kings to Help Generate Over $100 in Passive Income Per Year
October 13, 2024
Target, PepsiCo, and Kenvue have high yields and inexpensive valuations.
Via
The Motley Fool
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice
October 11, 2024
Sanofi is negotiating a potential sale of a 50% stake in its consumer health unit, Opella, to Clayton Dubilier & Rice. The deal, valued at $16.4 billion, could help Sanofi sharpen its focus on...
Via
Benzinga
Private Equity Firms Circle Sanofi's Consumer Health Business Amid Potential Spinoff
September 25, 2024
Sanofi plans to spin off its consumer healthcare division, which could be valued at over $16.8 billion. Private equity firms are bidding for the unit, with the spinoff expected by Q4 2024. Banks...
Via
Benzinga
Kenvue Set To Pop Like A Tylenol Gelcap? Golden Cross Looms On Stock Chart
September 10, 2024
Kenvue Inc., owner of major brands like Tylenol, is poised for a technical knockout with a Golden Cross pattern and legal win.
Via
Benzinga
Worried About a Stock Market Sell-Off? Consider Coca-Cola, Pepsi, and These 3 Safe Dividend Kings for Decades of Passive Income.
September 01, 2024
Via
The Motley Fool
Magnificent 7 Miss Out, 2 Cybersecurity Stocks Stand Firm, Retailers Lag In Volatile August: Here Are The Top S&P 500 Gainers And Losers
August 31, 2024
The equity market was volatile in August, with the weakness seen early in the month dissipating amid a rise in rate-cut bets.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Johnson & Johnson-Spin Off Kenvue Wins Lawsuit Over Pain Killer Tylenol 'Rapid Release' Gelcaps
August 30, 2024
Kenvue defends against a consumer lawsuit alleging that its Tylenol "Rapid Release" gelcaps did not relieve pain faster than regular tablets. A federal judge ruled the claims were preempted by FDA...
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Donald Trump Owns These 21 Dividend Kings. Should You?
August 26, 2024
Some of Trump's Dividend Kings deserve a crown more than others.
Via
The Motley Fool
Topics
Government
Exposures
Political
A Big CEO Move, Big Buffett Buys, and More
August 22, 2024
Motley Fool analysts talk over market news including earnings updates from Home Depot, Walmart, and Brinker.
Via
The Motley Fool
3 High-Yield Dividend ETFs to Buy to Generate Passive Income
August 18, 2024
ETFs offer a good way to own a diversified portfolio of income-producing equities.
Via
The Motley Fool
Topics
ETFs
7 Stable Dividend Stocks to Scoop Up on Discount
August 12, 2024
The market is looking shaky. To help calm your nerves and sleep easier at night, consider adding these stable dividend stocks to your holdings.
Via
InvestorPlace
Shopify, Palantir And Uber Are Among Top 10 Large Cap Gainers Last Week (Aug 4-Aug 10): Are The Others In Your Portfolio?
August 11, 2024
Top 10 best performing large-cap stocks last week: Shopify, Palantir, Axon, Fortinet, Trade Desk, Natera, SharkNinja, Zillow, Aspen Tech, Uber.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.